New I-O Targets Herald a Decade of Drugging the UndruggablePublished: Jan 16, 2023 By Heather McKenzieCompugen President and CEO Anat Cohen-Dayag, Ph.D./courtesy of CompugenThere’s a revolution unfolding in cancer therapeutics as…
Published: Feb 08, 2023 By Heather McKenzieYair Benita, Ph.D., chief technology officer, AION Labs/courtesy of Tsipi HaitovskyArtificial intelligence and machine learning applications are not the future of drug development; they’re already…
Surgical robotics is dominated by various versions of the da Vinci system from Intuitive Surgical, a competent but expensive tool that’s become a standard in modern advanced hospitals. It took…
Ofer Sharon, M.D., CEO, OncoHost/company courtesy Artificial intelligence and machine learning could change the face of cancer diagnostics.Today, physicians may run blood tests to find biomarkers specific to cancer, conduct imaging…
Radiation is commonly employed in hospitals around the world to treat tumors, typically using gamma ray beams of high energy photons, with a relatively long range, that penetrate all the…
Cancer therapies have proliferated over the past few decades, improving outcomes for many patients. But this variety requires accurate diagnostics and appropriate decision making to choose the optimal course of…
Israel's leading annual life science conference and exhibition to be held on May 16-18, 2023, at the David InterContinental Hotel in Tel AvivTEL AVIV, ISRAEL, April 18, 2023 /PRNewswire/ -- The…
Israeli startup Bone Sci Bio Ltd. is developing a product that treats bones by promoting the formation and repair of their tissue. The firm was set to present its new solution…
Israel is host to some 1,600 life sciences companies that employ more than 83,000 people, and the industry attracted a record $1.5 billion in 2018, up 25 percent year on…
More than 30 Israeli companies have accessed support to help bring health and medical technology innovations to the North of England in the last year, the Northern Health Science Alliance…
